This study provides an additional insight into the pro-tumorigenic role of sPLA2-X by dampening T cell immunity and implicates sPLA2-X as a potential target for cancer immunotherapy, although the involvement of EV hydrolysis by sPLA2-X in this situation remains unclear. Here, PLA2G10 is linked to cancer.